K Prasad - Cardiovascular drug reviews, 2006 - interscience.wiley.com C-reactive protein (CRP) plays a role in the pathogenesis of cardiovascular
disease. It is a marker and predictor of cardiovascular disease. CRP possesses
numerous cardiovascular effects (clotting, generation of oxygen radicals, ... Cited by 79 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org S Kinlay - Journal of the American College of Cardiology, 2007 - Elsevier This study sought to assess the contribution of low-density lipoprotein
(LDL)–dependent and LDL–independent effects of LDL-lowering therapies to
changes in C-reactive protein (CRP) in healthy or stable subjects. Cited by 59 - Related articles - BL Direct - All 17 versions
T Wolever, AL Gibbs, C Mehling, JL … - American Journal of Clinical Nutrition, 2008 - ajcn.cnfindpark.cn 2 Supported by the Canadian Institutes of Health Research (CIHR-MCT-44205). Key
foods were donated by Kellogg Canada Inc, Robin Hood (division of Smucker Foods
of Canada Co), HJ Heinz Co, Italpasta Ltd, Uncle Ben's Rice (division of ... Cited by 44 - Related articles - BL Direct - All 6 versions
MN Haan - Nature Clinical Practice Neurology, 2006 - nature.com Mary Haan is Professor of Epidemiology at the University of Michigan, School of
Public Health. She received her doctorate in epidemiology in 1986 from the
University of California, School of Public Health in Berkeley. Dr Haan has ... Cited by 32 - Related articles - BL Direct - All 4 versions
MH Gannagé-Yared, RR Azar, M Amm-Azar, S … - Metabolism, 2005 - Elsevier Pravastatin treatment decreased total cholesterol, low-density lipoprotein
cholesterol, and triglycerides levels by 24%, 32%, and 14%, respectively (P <
.05 for all), but did not affect glucose and insulin levels, the (QUICKI) ... Cited by 25 - Related articles - All 10 versions
- ►asnjournals.org M Goicoechea, SG de Vinuesa, V Lahera, V … - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol Although substantial evidence suggests that treatment of dyslipidemia with
statins reduces mortality and morbidity that are associated with cardiovascular
disease, only a few studies have examined the efficacy of statins on ... Cited by 14 - Related articles - All 6 versions
DW Sommeijer, HR Hansen, R Van Oerle, K … - Journal of Thrombosis and Haemostasis, 2006 - interscience.wiley.com Summary. Objective: To determine the relationship between abnormalities in blood
coagulation and prevalent or incident cardiovascular complications in Type 2
diabetes. Design and methods: Prospective cohort study of 128 patients with ... Cited by 9 - Related articles - BL Direct - All 3 versions
RFM van der Putten, H te Velthuis, LA Aarden … - Clinical Chemical Laboratory Medicine, 2005 - reference-global.com Tissue factor, the main initiator of blood coagulation, is shed into plasma by
blood cells and endothelium. While studying such circulating plasma tissue
factor with a commercially available immunoassay, we found unsatisfactory ... Cited by 7 - Related articles - BL Direct - All 7 versions
R Candido, M Zanetti - Ital Heart J, 2005 - milray.org Patients with diabetes mellitus (type 1 or type 2) have a high prevalence of
cardiac morbidity and mortality with up to 75% be- ing from cardiovascular
disease1,2. Macro- angiopathy in diabetes is manifested by ac- celerated ... Cited by 5 - Related articles - View as HTML - All 3 versions
